FDA Adverse Event Injury Summary report: N

ENDURANT

MDR report key: 2912250 · Received January 11, 2013

Report

Report Number
2953200-2013-00076
Event Type
Injury
Date Received
January 11, 2013
Date of Event
December 14, 2012
Report Date
December 14, 2012
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P100021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION, RESULTS: INHERENT RISK OF PROCEDURE (ENDOLEAK); PATIENT'S CONDITION AFFECTED EFFECTIVENESS OF DEVICE (ANGULATED AORTIC NECK); INCORRECT TECHNIQUE/PROCEDURE (STENT GRAFT WAS USED IN A PATIENT WITH A SEVERELY ANGULATED AORTIC NECK). CONCLUSION: DEVICE FAILURE/LACK OF EFFECTIVENESS RELATED TO PATIENT CONDITION (ANGULATED AORTIC NECK); OPERATIONAL CONTEXT CONTRIBUTED TO EVENT (STENT GRAFT WAS USED IN A PATIENT WITH A SEVERELY ANGULATED AORTIC NECK).

Description of Event or Problem · 1

AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 60 MM DIAMETER X 61 MM LENGTH FUSIFORM SHAPED ABDOMINAL AORTIC ANEURYSM APPROXIMATELY ONE MONTH AGO. THE PROXIMAL NECK WAS 28 MM IN DIAMETER AND THE AORTIC NECK ANGLE WAS 100 DEGREES. AFTER THE ENDURANT BIFURCATED STENT GRAFT ENBF3216C145EJ WAS DEPLOYED THERE WAS A TYPE I ENDOLEAK SEEN ON ANGIOGRAM. AN ENDURANT CUFF ENCF3232C49EJ WAS IMPLANTED; HOWEVER, THE ENDOLEAK DID NOT RESOLVE AND TOUCH-UP WAS DONE WITH A BALLOON. THE TYPE I ENDOLEAK STILL DID NOT RESOLVE. THE ENDOLEAK WAS ATTRIBUTED THE AORTIC NECK ANGLE BELOW THE RENAL ARTERY WHICH MADE THIS A DIFFICULT CASE. THE DECISION WAS MADE TO NOT FURTHER INTERVENE AS THE ENDOLEAK MAY RESOLVE ON IT'S OWN. THE PHYSICIAN WILL MONITOR THE PATIENT. NO FURTHER INFORMATION WAS PROVIDED AND THE PATIENT IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
16568 ENDURANT SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC IRELAND V01141427

Patients

Seq Age Sex Outcome Treatment
1 00080 YR Required Intervention